Quantcast

Actos Bladder Cancer Concerns

Actos Bladder Cancer Lawsuit Actos is a recent drug in the thiazolidinedione class, which is used by itself or in combination with other drugs (including insulin) for the treatment of type 2 diabetes. The medicine lowers blood glucose levels and increases the body’s sensitivity to insulin.  The US Food and Drug Administration (FDA) approved Actos … [Read more...]

Drug Manufacturer Watson Sues FDA Over Generic Actos Release

Watson Pharmaceuticals has filed a lawsuit against the FDA for denying shared exclusivity, despite the fact that the drug company followed all the FDA’s requirements. Watson planned to release the generic version of Takeda Pharmaceutical’s controversial Actos drug on August 17th. In 2010, Watson got approval to market the generic pioglitazone … [Read more...]

Study Reveals Obesity Rates in the South are Some of Highest in the Country; South Carolina Places 8th

A new study shows that 12 states have obesity rates higher than 30%, and 26 of the 30 states with high obesity rates are in the South and Midwest. South Carolina ranks number 8 in the study, with an obesity rate of 30.8%. Five years ago, South Carolina ranked 10th in the nation, with between three or four people dying each day from diabetes and … [Read more...]

Actos Increases Bladder Cancer Risk Compared to Different Class of Diabetes Drugs

A new study released earlier this month, and published in the Journal of the National Cancer Institute, found that thiazolidinedione (TZD) drugs like Actos were more likely to cause bladder cancer than a different class of drugs called sulfonylurea drugs. Patients who took TZD drugs were two to three times more likely to develop bladder cancer than … [Read more...]

Actos Bellwether Cases Scheduled for MDL 2299

Presiding Judge Rebecca Doherty has issued a detailed schedule for proceedings in the Actos Multidistrict Litigation (MDL) 2299. Bellwether trials, which are typical in MDLs, are early trials designed by both parties to gauge the juries’ reactions to evidence. The trials picked as bellwether cases normally represent egregious cases. Attorneys … [Read more...]

Actos Lawsuit

The Strom Law Firm is now accepting product liability and personal injury cases regarding the use of Actos and its link to bladder cancer.  Call us right now for a free case review to see if we can help you. 803.252.4800 Actos drug maker Takeda Pharmaceutical Co. Ltd. was hit in California yesterday with what is expected to be the first of … [Read more...]

Despite Outcry, Still No Actos Recall in Europe or the US

Actos Lawsuit Although the trial against Takeda Pharmaceuticals, manufacturers of the controversial diabetes drug Actos, continues to heat up Food and Drug Administration (FDA) and the European Medicines Agency have not issued recalls of the drug. In 2011, citing strong evidence of Actos’s link to bladder cancer, as well as heart failure, … [Read more...]

Whistleblower Case Related to Actos Investigation Unsealed

In March of this year, US District Judge F. Dennis Saylor had Dr. Helen Ge’s whistleblower case against Takeda Pharmaceuticals unsealed. The case was initially filed in 2010 against the pharmaceutical giant, claiming the company failed to properly report adverse side effects, such as bladder cancer and congestive heart failure, to the FDA. Dr. … [Read more...]

10,000 Lawsuits: Actos Injury Filing in Multidistrict Litigation 2299 Streamlined

Judge Rebecca Doherty signed a Direct Filing Order in April that allows any plaintiff to add their lawsuit directly to Actos Multidistrict Litigation 2299. In December 2011, a federal Judicial Panel consolidated several Actos lawsuits under one federal court, in Lafayette, Louisiana. The Honorable Rebecca Doherty is presiding over the … [Read more...]

FDA Rejects Actos-Based Drug for the 2nd Time

In April of this year, the FDA rejected Takeda Pharmaceuticals’ Actos style new drug, called alogliptin, citing a lack of data regarding the drug’s side effects. Takeda Pharmaceuticals has been under fire in the last two years from patients who claim their drugs, specifically Avandia and Actos, cause severe side effects, and that Takeda knew about … [Read more...]

BestLawyers.comAVBetter Business Bureau